Used in solid-phase peptide synthesis, particularly for constructing peptide sequences requiring enhanced stability and reduced enzymatic degradation. The di-methyl substitution on the tyrosine aromatic ring increases hydrophobicity and steric hindrance, which can improve peptide resistance to proteolysis and influence receptor binding selectivity. The Fmoc group allows for mild, base-labile protection during stepwise synthesis, making it compatible with standard Fmoc-strategy protocols. Commonly employed in the development of bioactive peptides, enzyme inhibitors, and peptide-based pharmaceuticals where modified amino acids fine-tune biological activity and pharmacokinetic properties.